Download Files:

Procyclidine (hydrochloride)

$84$92

Products Details

Product Description

– Procyclidine (Tricyclamol, (±)-Procyclidine) hydrochloride , an anticholinergic agent, is a muscarinic receptor antagonist that also has the properties of an N-methyl-D-aspartate (NMDA) antagonist. Procyclidine hydrochloride can be used in studies of Parkinson’s disease and related psychiatric disorders such as Soman-induced epilepsy[1][2].

Web ID

– HY-B1487

Storage Temperature

– 4°C (Powder, sealed storage, away from moisture)

Shipping

– Room Temperature

Applications

– Neuroscience-Neurodegeneration

Molecular Formula

– C19H30ClNO

References

– [1]Yun-Bae Kim, et al. Effects of combinational prophylactics composed of physostigmine and procyclidine on soman-induced lethality, seizures and brain injuries. Environ Toxicol Pharmacol. 2002 Jan;11(1):15-21.|[2]Ulrich Ettinger, et al. Effects of procyclidine on eye movements in schizophrenia. Neuropsychopharmacology. 2003 Dec;28(12):2199-208.

CAS Number

– 1508-76-5

Molecular Weight

– 323.90

Compound Purity

– 99.55

SMILES

– OC(C1=CC=CC=C1)(C2CCCCC2)CCN3CCCC3.[H]Cl

Clinical Information

– Launched

Research Area

– Neurological Disease

Solubility

– DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 5.56 mg/mL (ultrasonic;warming;heat to 60°C)

Target

– iGluR;mAChR

Isoform

– NMDA Receptor

Pathway

– GPCR/G Protein;Membrane Transporter/Ion Channel;Neuronal Signaling

Product type

– Reference compound

Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.